5 High Growth Pharma Stocks that are Profitable

Page 1 of 5

In this piece, we will take a look at five high growth pharma stocks that are profitable. For more stocks, head on over to 13 High Growth Pharma Stocks that are Profitable.

5. Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Q/Q Sales Growth: 80%

Number of Hedge Fund Holders in Q3 2022: 21

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company that develops treatments for lymphoma, immune disorders, cancer, and leukemia. The firm is based in San Diego, California.

Halozyme Therapeutics, Inc. (NASDAQ:HALO)’s third quarter of 2022 results saw the firm bring in $209 million in revenue, which marked a strong 80% annual growth. 21 of the 920 hedge funds polled by Insider Monkey during the same time period had also invested in the firm.

Halozyme Therapeutics, Inc. (NASDAQ:HALO)’s largest investor in our database is Richard Driehaus’ Driehaus Capital which owns 1.3 million shares that are worth $76 million.

Follow Halozyme Therapeutics Inc. (NASDAQ:HALO)



Page 1 of 5